OTCMKTS:ARYAU ARYA Sciences Acquisition (ARYAU) Stock Price, News & Analysis $19.51 +0.17 (+0.88%) As of 07/1/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ARYA Sciences Acquisition Stock (OTCMKTS:ARYAU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ARYAU alerts:Sign Up Key Stats Today's Range$19.50▼$19.6950-Day Range$19.51▼$19.5152-Week Range$10.45▼$22.00Volume1,000 shsAverage Volume6,785 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ARYA Sciences Acquisition (OTCMKTS: ARYAU) is a special purpose acquisition company (SPAC) formed to raise capital through an initial public offering and to effect a business combination with one or more target companies. Organized as a Cayman Islands exempted company, ARYA Sciences Acquisition is sponsored by ARYA Sciences and focuses on identifying opportunities within the human health and life sciences sectors. The SPAC structure provides a flexible vehicle for private companies in these industries to access public markets and accelerate growth strategies. The company’s management team brings together individuals with experience in biotechnology, healthcare investing and corporate development. Although ARYA Sciences Acquisition has not yet announced a definitive business combination, its stated objective is to partner with organizations that leverage data analytics, digital technologies or novel therapeutic platforms to address unmet medical needs. By targeting businesses at the intersection of science and technology, the SPAC seeks to create value for shareholders through strategic transactions that drive innovation in patient care. Trading on the OTC Markets under the ticker ARYAU, ARYA Sciences Acquisition continues to evaluate prospective merger candidates across North America and other key markets. With its blank‐check structure and industry‐focused mandate, the company aims to complete a transaction that brings a high‐growth life sciences enterprise into the public domain, supporting further research, development and commercialization efforts.AI Generated. May Contain Errors. Read More Receive ARYAU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARYAU Stock News HeadlinesADGM stock touches 52-week low at $0.77 amid market challengesJanuary 17, 2025 | msn.comNautilus Biotechnology: Hold Rating Amidst Anticipated 2025 Launch and Platform Optimization ChallengesOctober 31, 2024 | markets.businessinsider.comREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.September 16 at 2:00 AM | Paradigm Press (Ad)Q3 2024 Teradyne Inc Earnings CallOctober 25, 2024 | finance.yahoo.com10 Trending AI Stocks to Watch for the Rest of 2024September 27, 2024 | insidermonkey.comChico’s Arya Pocock wraps Youth of the Year competitionSeptember 21, 2024 | msn.comMSCI Rejig: HDFC Bank likely to see $1.8 billion inflows, Vodafone Idea, RVNL and 6 other stocks likely to be addedAugust 13, 2024 | msn.comEQL Pharma AB (EQL.ST)August 13, 2024 | finance.yahoo.comSee More Headlines ARYAU Stock Analysis - Frequently Asked Questions How have ARYAU shares performed this year? ARYA Sciences Acquisition's stock was trading at $19.51 at the beginning of 2025. Since then, ARYAU shares have increased by 0.0% and is now trading at $19.51. How do I buy shares of ARYA Sciences Acquisition? Shares of ARYAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Conglomerates Sub-IndustryTrading Current SymbolOTCMKTS:ARYAU CIKN/A WebN/A Phone212-284-2300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:ARYAU) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARYA Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARYA Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.